NCT03600649 2023-11-21
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
Salarius Pharmaceuticals, LLC
Phase 1 Unknown
Salarius Pharmaceuticals, LLC
Salarius Pharmaceuticals, LLC
Maria Sklodowska-Curie National Research Institute of Oncology
Maria Sklodowska-Curie National Research Institute of Oncology
Systems Medicine LLC